SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-117676
Filing Date
2016-08-09
Accepted
2016-08-09 16:06:55
Documents
66
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v445167_10q.htm 10-Q 538098
2 EXHIBIT 31.1 v445167_ex31-1.htm EX-31.1 9939
3 EXHIBIT 31.2 v445167_ex31-2.htm EX-31.2 9559
4 EXHIBIT 32.1 v445167_ex32-1.htm EX-32.1 4137
5 EXHIBIT 32.2 v445167_ex32-2.htm EX-32.2 3967
  Complete submission text file 0001144204-16-117676.txt   4418719

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvax-20160630.xml EX-101.INS 955026
7 XBRL TAXONOMY EXTENSION SCHEMA nvax-20160630.xsd EX-101.SCH 41187
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20160630_cal.xml EX-101.CAL 46285
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20160630_def.xml EX-101.DEF 271058
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20160630_lab.xml EX-101.LAB 365815
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20160630_pre.xml EX-101.PRE 316895
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 161817922
SIC: 2836 Biological Products, (No Diagnostic Substances)